Comparative In Vitro Activities of GAR-936 against Aerobic and Anaerobic Animal and Human Bite Wound Pathogens

GAR-936 is a new semisynthetic glycylcycline with a broad antibacterial spectrum, including tetracycline-resistant strains. The in vitro activities of GAR-936, minocycline, doxycycline, tetracycline, moxifloxacin, penicillin G, and erythromycin were determined by agar dilution methods against 268 ae...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Goldstein, Ellie J. C., Citron, Diane M., Merriam, C. Vreni, Warren, Yumi, Tyrrell, Kerin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90146/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10991855/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.10.2747-2751.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!